Eyenovia announces appointments of dr. ellen strahlman and dr. ram palanki as new and independent members of its board of directors

New york, july 07, 2022 (globe newswire) -- eyenovia, inc. (nasdaq: eyen), an ophthalmic pharmaceutical technology company developing a pipeline of late-stage microdose array print (map™) therapeutics, today announced that it has appointed dr. ellen strahlman and dr. ram palanki as new and independent members of its board of directors. with these appointments, the eyenovia board will expand to eight seats, from six currently.
EYEN Ratings Summary
EYEN Quant Ranking